compounded glp-1 ban Did the FDA Semaglutide and Tirzepatide? Compounded" GLP-1 drugs | Health

According to the British National Formulary (BNF) and specialist hepatology guidance, patients with established hepatic impairmentparticularly those with cirrhosismay be advised to limit paracetamol to a maximum of 23 g daily, though this should be determined on an individual basis by a clinician

Sublingual and oral formulations: While the standard formulation for compounded GLP-1 medications is injectable, some pharmacies have developed alternative delivery methods, including sublingual drops or troches

D.LecourtE.DewulfE

The 2026 EASO pharmacotherapy update formalised this evidence by ranking tirzepatide above semaglutide for obesity management, while simultaneously supporting semaglutide as the better-documented agent for liver fibrosis improvement in metabolic dysfunction-associated steatohepatitis (MASH), based on more mature phase 3 ESSENCE trial data [1]

Sourced product has unverified purity, sterility, and dosing